(Q38088686)

28 August 2017

title

Corticosteroids in Duchenne muscular dystrophy: major variations in practice (English)

1 reference

Duchenne muscular dystrophy

28 August 2017

main subject

1 reference

Elaine McColl

7

0 references

author name string

Robert C Griggs

1

1 reference

28 August 2017

Barbara E Herr

2

1 reference

28 August 2017

Allen Reha

3

1 reference

28 August 2017

Gary Elfring

4

1 reference

28 August 2017

Leone Atkinson

5

1 reference

28 August 2017

Valerie Cwik

6

1 reference

28 August 2017

Rabi Tawil

8

1 reference

28 August 2017

Shree Pandya

9

1 reference

28 August 2017

Michael P McDermott

10

1 reference

28 August 2017

Kate Bushby

11

1 reference

28 August 2017

publication date

25 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

48

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

27-31

1 reference

Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy

28 August 2017

cites work

1 reference

Duchenne muscular dystrophy: survival by cardio-respiratory interventions

21 January 2018

1 reference

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

21 January 2018

1 reference

Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy

21 January 2018

1 reference

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

21 January 2018

1 reference

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

21 January 2018

1 reference

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

21 January 2018

1 reference

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

21 January 2018

1 reference

Deflazacort treatment of Duchenne muscular dystrophy

21 January 2018

1 reference

Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy

21 January 2018

1 reference

Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols

21 January 2018

1 reference

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

21 January 2018

1 reference

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule

21 January 2018

1 reference

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

21 January 2018

1 reference

Remission of clinical signs in early duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy

21 January 2018

1 reference

An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy

21 January 2018

1 reference

Early prednisone treatment in Duchenne muscular dystrophy

21 January 2018

1 reference

Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy

21 January 2018

1 reference

Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management

21 January 2018

1 reference

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy

21 January 2018

1 reference

145th ENMC International Workshop: planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD), 22-24th October 2006, Naarden, The Netherlands

21 January 2018

1 reference

Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.23831

1 reference

28 August 2017

1 reference